LUMEN TECHNOLOGIES INC (1CYTH.MI) Stock Fundamental Analysis
BIT:1CYTH - US5502411037 - Common Stock
5.129 EUR
+1.07 (+26.36%)
Overall 1CYTH gets a fundamental rating of 2 out of 10. We evaluated 1CYTH against 30 industry peers in the Diversified Telecommunication Services industry. The financial health of 1CYTH is average, but there are quite some concerns on its profitability. 1CYTH has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
In the past year 1CYTH has reported negative net income.
In the past year 1CYTH had a positive cash flow from operations.
1CYTH had negative earnings in 4 of the past 5 years.
In the past 5 years 1CYTH always reported a positive cash flow from operatings.
1.2 Ratios
1CYTH's Return On Assets of -3.58% is on the low side compared to the rest of the industry. 1CYTH is outperformed by 80.00% of its industry peers.
1CYTH has a Return On Invested Capital of 1.05%. This is amonst the worse of the industry: 1CYTH underperforms 80.00% of its industry peers.
The Average Return On Invested Capital over the past 3 years for 1CYTH is below the industry average of 7.31%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -3.58% | ||
| ROE | N/A | ||
| ROIC | 1.05% |
ROA(3y)-11.28%
ROA(5y)-6.48%
ROE(3y)-832.11%
ROE(5y)-498.04%
ROIC(3y)3.43%
ROIC(5y)4.35%
1.3 Margins
1CYTH's Operating Margin of 3.21% is on the low side compared to the rest of the industry. 1CYTH is outperformed by 73.33% of its industry peers.
1CYTH's Operating Margin has declined in the last couple of years.
1CYTH's Gross Margin of 47.68% is in line compared to the rest of the industry. 1CYTH outperforms 43.33% of its industry peers.
In the last couple of years the Gross Margin of 1CYTH has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 3.21% | ||
| PM (TTM) | N/A | ||
| GM | 47.68% |
OM growth 3Y-44.91%
OM growth 5Y-27.05%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.94%
GM growth 5Y-3.18%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), 1CYTH is destroying value.
1CYTH has more shares outstanding than it did 1 year ago.
1CYTH has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, 1CYTH has an improved debt to assets ratio.
2.2 Solvency
1CYTH has an Altman-Z score of -0.14. This is a bad value and indicates that 1CYTH is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -0.14, 1CYTH is doing worse than 83.33% of the companies in the same industry.
1CYTH has a debt to FCF ratio of 19.08. This is a negative value and a sign of low solvency as 1CYTH would need 19.08 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 19.08, 1CYTH is doing worse than 70.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 19.08 | ||
| Altman-Z | -0.14 |
ROIC/WACC0.17
WACC6.13%
2.3 Liquidity
1CYTH has a Current Ratio of 2.13. This indicates that 1CYTH is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 2.13, 1CYTH belongs to the best of the industry, outperforming 96.67% of the companies in the same industry.
1CYTH has a Quick Ratio of 2.10. This indicates that 1CYTH is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 2.10, 1CYTH belongs to the top of the industry, outperforming 96.67% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.13 | ||
| Quick Ratio | 2.1 |
3. Growth
3.1 Past
1CYTH shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -11.11%.
Looking at the last year, 1CYTH shows a decrease in Revenue. The Revenue has decreased by -6.50% in the last year.
1CYTH shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -9.39% yearly.
EPS 1Y (TTM)-11.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%76.92%
Revenue 1Y (TTM)-6.5%
Revenue growth 3Y-12.68%
Revenue growth 5Y-9.39%
Sales Q2Q%-5.39%
3.2 Future
The Earnings Per Share is expected to grow by 5.71% on average over the next years.
Based on estimates for the next years, 1CYTH will show a decrease in Revenue. The Revenue will decrease by -2.86% on average per year.
EPS Next Y-213.49%
EPS Next 2Y-67.08%
EPS Next 3Y-25.84%
EPS Next 5Y5.71%
Revenue Next Year-4.43%
Revenue Next 2Y-5.13%
Revenue Next 3Y-4.08%
Revenue Next 5Y-2.86%
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
1CYTH reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for 1CYTH. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
1CYTH's Enterprise Value to EBITDA is on the same level as the industry average.
1CYTH's Price/Free Cash Flow ratio is rather cheap when compared to the industry. 1CYTH is cheaper than 90.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 6.59 | ||
| EV/EBITDA | 6.47 |
4.3 Compensation for Growth
A cheap valuation may be justified as 1CYTH's earnings are expected to decrease with -25.84% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-67.08%
EPS Next 3Y-25.84%
5. Dividend
5.1 Amount
No dividends for 1CYTH!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
BIT:1CYTH (9/10/2025, 7:00:00 PM)
5.129
+1.07 (+26.36%)
Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupTelecommunication Services
GICS IndustryDiversified Telecommunication Services
Earnings (Last)
Earnings (Next)
Inst Owners71.48%
Inst Owner ChangeN/A
Ins Owners7.9%
Ins Owner ChangeN/A
Market Cap5.26B
Analysts70.53
Price Target4.5 (-12.26%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly Dividend0
Dividend Growth(5Y)-68.79%
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)70.47%
Min EPS beat(2)52.11%
Max EPS beat(2)88.84%
EPS beat(4)3
Avg EPS beat(4)91.86%
Min EPS beat(4)-45.54%
Max EPS beat(4)272.03%
EPS beat(8)4
Avg EPS beat(8)-65.72%
EPS beat(12)7
Avg EPS beat(12)-22.95%
EPS beat(16)9
Avg EPS beat(16)-14.81%
Revenue beat(2)0
Avg Revenue beat(2)-1.34%
Min Revenue beat(2)-2.58%
Max Revenue beat(2)-0.09%
Revenue beat(4)1
Avg Revenue beat(4)-0.64%
Min Revenue beat(4)-2.58%
Max Revenue beat(4)1.96%
Revenue beat(8)1
Avg Revenue beat(8)-1.16%
Revenue beat(12)1
Avg Revenue beat(12)-1.38%
Revenue beat(16)1
Avg Revenue beat(16)-1.51%
PT rev (1m)4.55%
PT rev (3m)8.43%
EPS NQ rev (1m)20.14%
EPS NQ rev (3m)16.63%
EPS NY rev (1m)35.07%
EPS NY rev (3m)35.18%
Revenue NQ rev (1m)-0.58%
Revenue NQ rev (3m)-0.19%
Revenue NY rev (1m)0.14%
Revenue NY rev (3m)0.17%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.48 | ||
| P/FCF | 6.59 | ||
| P/OCF | 1.41 | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | 6.47 |
EPS(TTM)-0.17
EYN/A
EPS(NY)-0.5
Fwd EYN/A
FCF(TTM)0.78
FCFY15.18%
OCF(TTM)3.64
OCFY70.94%
SpS10.64
BVpS-0.49
TBVpS-4.25
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -3.58% | ||
| ROE | N/A | ||
| ROCE | 1.4% | ||
| ROIC | 1.05% | ||
| ROICexc | 1.11% | ||
| ROICexgc | 1.33% | ||
| OM | 3.21% | ||
| PM (TTM) | N/A | ||
| GM | 47.68% | ||
| FCFM | 7.31% |
ROA(3y)-11.28%
ROA(5y)-6.48%
ROE(3y)-832.11%
ROE(5y)-498.04%
ROIC(3y)3.43%
ROIC(5y)4.35%
ROICexc(3y)3.6%
ROICexc(5y)4.47%
ROICexgc(3y)6.03%
ROICexgc(5y)8.09%
ROCE(3y)4.57%
ROCE(5y)5.8%
ROICexcg growth 3Y-47.53%
ROICexcg growth 5Y-31.85%
ROICexc growth 3Y-41.43%
ROICexc growth 5Y-24.11%
OM growth 3Y-44.91%
OM growth 5Y-27.05%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.94%
GM growth 5Y-3.18%
F-Score5
Asset Turnover0.39
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 19.08 | ||
| Debt/EBITDA | 5.36 | ||
| Cap/Depr | 120.27% | ||
| Cap/Sales | 26.88% | ||
| Interest Coverage | 0.31 | ||
| Cash Conversion | 133.77% | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.13 | ||
| Quick Ratio | 2.1 | ||
| Altman-Z | -0.14 |
F-Score5
WACC6.13%
ROIC/WACC0.17
Cap/Depr(3y)102.09%
Cap/Depr(5y)91.52%
Cap/Sales(3y)21.07%
Cap/Sales(5y)19.19%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-11.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%76.92%
EPS Next Y-213.49%
EPS Next 2Y-67.08%
EPS Next 3Y-25.84%
EPS Next 5Y5.71%
Revenue 1Y (TTM)-6.5%
Revenue growth 3Y-12.68%
Revenue growth 5Y-9.39%
Sales Q2Q%-5.39%
Revenue Next Year-4.43%
Revenue Next 2Y-5.13%
Revenue Next 3Y-4.08%
Revenue Next 5Y-2.86%
EBIT growth 1Y-28.35%
EBIT growth 3Y-51.9%
EBIT growth 5Y-33.9%
EBIT Next Year396.91%
EBIT Next 3Y74.63%
EBIT Next 5Y39.36%
FCF growth 1Y243.21%
FCF growth 3Y-32.61%
FCF growth 5Y-18.43%
OCF growth 1Y78.32%
OCF growth 3Y-12.65%
OCF growth 5Y-8.29%